| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 816 | 2016 |
| Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen TN Christ, W Stock, RW Knoebel Journal of Oncology Pharmacy Practice 24 (4), 299-308, 2018 | 48 | 2018 |
| Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center M Mearis, JW Shega, RW Knoebel Journal of Pain and Symptom Management 48 (3), 451-458, 2014 | 41 | 2014 |
| Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome RW Knoebel, M Lo, CW Crank Journal of Oncology Pharmacy Practice 17 (3), 147-154, 2011 | 38 | 2011 |
| Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia BA Derman, M Streck, J Wynne, TN Christ, E Curran, W Stock, ... Leukemia & lymphoma 61 (3), 614-622, 2020 | 34 | 2020 |
| Treatment disparities among the Black population and their influence on the equitable management of chronic pain RW Knoebel, JV Starck, P Miller Health Equity 5 (1), 596-605, 2021 | 26 | 2021 |
| Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia N Khan, A Hantel, RW Knoebel, A Artz, RA Larson, LA Godley, ... Leukemia & Lymphoma 58 (9), 2127-2133, 2017 | 25 | 2017 |
| Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia M Vicente, M Al-Nahedh, S Parsad, RW Knoebel, J Pisano, NN Pettit Journal of Oncology Pharmacy Practice 23 (8), 575-581, 2017 | 20 | 2017 |
| Pepsi® or Coke®? Influence of acid on dasatinib absorption RW Knoebel, RA Larson Journal of oncology pharmacy practice 24 (2), 156-158, 2018 | 18 | 2018 |
| The ImPreSS trial: implementation of point-of-care pharmacogenomic decision support in perioperative care TM Truong, J Apfelbaum, S Shahul, M Anitescu, K Danahey, RW Knoebel, ... Clinical pharmacology and therapeutics 106 (6), 1179, 2019 | 16 | 2019 |
| Posaconazole–digoxin drug–drug interaction mediated by inhibition of P-glycoprotein AC Shumaker, HM Bullard, J Churpek, RW Knoebel Journal of Oncology Pharmacy Practice 25 (7), 1758-1761, 2019 | 13 | 2019 |
| Pharmacogenomic considerations for medications in the perioperative setting EH Jhun, JL Apfelbaum, DM Dickerson, S Shahul, R Knoebel, K Danahey, ... Pharmacogenomics 20 (11), 813-827, 2019 | 13 | 2019 |
| Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings PH Hsieh, AJ Kacew, M Dreyer, AV Serritella, RW Knoebel, ... NPJ Breast Cancer 8 (1), 32, 2022 | 12 | 2022 |
| Impact of a clinical decision support tool on cancer pain management in opioid-tolerant inpatients TN Christ, JJ Villadolid, A Choksi, M Malec, RW Knoebel Hospital pharmacy, 0018578717746369, 2018 | 12 | 2018 |
| Changes in intravenous immunoglobulin usage for hypogammaglobulinemia after implementation of a stewardship program BA Derman, Z Schlei, S Parsad, K Mullane, RW Knoebel JCO Oncology Practice 17 (3), e445-e453, 2021 | 11 | 2021 |
| Medication management in older adults and interprofessional education: a needs assessment T Kostas, R Knoebel, S Levine Gerontology & Geriatrics Education 41 (1), 100-108, 2020 | 8 | 2020 |
| Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing YM Lee, K Danahey, RW Knoebel, MJ Ratain, DO Meltzer, PH O’Donnell Pharmacogenetics and Genomics 29 (2), 23-30, 2019 | 8 | 2019 |
| Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+ cytarabine RW Knoebel, A McQuary, P Becker, P Hendrie, S Petersdorf, ... Leukemia Research 35 (9), e164-e166, 2011 | 5 | 2011 |
| Implementation of pharmacogenomics into inpatient general medicine T Chen, PH O’Donnell, M Middlestadt, GW Ruhnke, K Danahey, ... Pharmacogenetics and genomics 33 (2), 19-23, 2023 | 4 | 2023 |
| Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application BA Borden, EH Jhun, K Danahey, E Schierer, JL Apfelbaum, M Anitescu, ... The pharmacogenomics journal 21 (6), 691-711, 2021 | 4 | 2021 |
Mark RatainLeon O. Jacobson Professor of Medicine, The University of ChicagoVerified email at uchicago.edu
